HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

Go back to HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition
BIOTELEMETRY (NASDAQ: BEAT) Delayed: 0.43 +0.01 (2.38%)
Previous Close $0.42    52 Week High $21.68 
Open $0.42    52 Week Low $8.74 
Day High $0.43    P/E N/A 
Day Low $0.40    EPS $-0.46 
Volume 491,542